Autologous pericardial annuloplasty linked to lower TR recurrence in rheumatic heart disease

This retrospective cohort study compared two surgical techniques for functional tricuspid regurgitation secondary to rheumatic heart disease. The analysis included 251 consecutive RHD patients undergoing tricuspid annuloplasty, with 139 receiving autologous pericardial soft-ring annuloplasty (P-TVP) and 112 receiving prosthetic ring annuloplasty (A-TVP). After propensity score matching, 64 matched pairs were analyzed with follow-up assessments at 6, 24, 48, and 96 months.

The study found that early outcomes were similar between the two surgical groups, though specific effect sizes and absolute numbers were not reported. At later time points, recurrence of moderate tricuspid regurgitation was significantly lower in the P-TVP group at both 48 and 96 months (both P < 0.05). The analysis also examined right-heart remodeling outcomes, though specific results for these secondary outcomes were not detailed in the provided data.

Safety and tolerability data were not reported. Key limitations include the retrospective observational design, which can only show associations rather than establish causation, and partially missing follow-up data that required multiple imputation. The findings are specific to RHD patients undergoing tricuspid annuloplasty and cannot be generalized to other populations or etiologies of tricuspid regurgitation. While the long-term TR recurrence difference appears favorable for the autologous pericardial approach, clinicians should interpret these results cautiously given the study's methodological constraints.

Researchers looked back at medical records to compare two surgical methods for fixing a leaky tricuspid heart valve in patients with rheumatic heart disease. The study involved 251 patients who had valve repair surgery. One group had surgery using a ring made from the patient's own pericardial tissue (P-TVP), while the other group had surgery using a manufactured prosthetic ring (A-TVP).

The main finding was that patients who received the repair using their own tissue had significantly lower rates of the valve leaking again (recurrence of moderate tricuspid regurgitation) at both 4 years and 8 years after surgery. Early results after surgery were similar between the two groups.

It is important to be careful with these results. This was a retrospective study, meaning researchers analyzed past patient data rather than assigning treatments randomly. Some follow-up information was also missing, which required statistical estimation. Therefore, the study shows a link between the tissue-based technique and better long-term results, but it does not prove the technique caused the better outcome. The findings apply specifically to patients with rheumatic heart disease and may not apply to others. Readers should see this as promising information that needs confirmation from more rigorous, prospective studies.